Raymond James Financial Services Advisors, Inc. Avid Bioservices, Inc. Transaction History

Raymond James Financial Services Advisors, Inc.

$73.5 Billion
Q3 2024

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 08, 2022	SELL	$20.7 - $34.18 $196,484 - $324,436	-9,492 Closed	0 $0
Q3 2021 Nov 02, 2021	SELL	$19.05 - $28.32 $101,517 - $150,917	-5,329 Reduced 35.96%	9,492 $205,000
Q2 2021 Aug 11, 2021	SELL	$18.93 - $25.65 $41,532 - $56,276	-2,194 Reduced 12.89%	14,821 $380,000
Q1 2021 May 14, 2021	BUY	$11.86 - $21.77 $25,404 - $46,631	2,142 Added 14.4%	17,015 $310,000
Q4 2020 Feb 12, 2021	SELL	$7.25 - $11.76 $7 - $11	-1 Reduced 0.01%	14,873 $172,000
Q3 2020 Nov 04, 2020	SELL	$6.53 - $8.6 $14,659 - $19,307	-2,245 Reduced 13.11%	14,874 $113,000
Q2 2020 Jul 17, 2020	BUY	$4.11 - $6.78 $1,089 - $1,796	265 Added 1.57%	17,119 $112,000
Q1 2020 Apr 21, 2020	SELL	$3.15 - $7.39 $4,501 - $10,560	-1,429 Reduced 7.82%	16,854 $86,000
Q4 2019 Feb 12, 2020	BUY	$5.01 - $8.16 $9,919 - $16,156	1,980 Added 12.15%	18,283 $140,000
Q2 2018 Jul 30, 2018	BUY	$3.1 - $3.93 $50,539 - $64,070	16,303 New	16,303 $64,000

Others Institutions Holding CDMO

# of Institutions

183

Shares Held

67.8M

Call Options Held

89.9K

Put Options Held

118K

Black Rock Inc. New York, NY

5.11M
Shares

$62.8 Million
0.0% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

4.19M
Shares

$51.5 Million
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

3.85M
Shares

$47.3 Million
0.0% of portfolio
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct

3.82M
Shares

$46.9 Million
0.12% of portfolio
Altra Vue Capital, LLC Bellevue, WA

3.8M
Shares

$46.7 Million
4.48% of portfolio

View Full List

About Avid Bioservices, Inc.

Ticker CDMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,167,500
Market Cap $765M
Description
Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant pro...

More about CDMO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.

Account